Company intelligence / Profile preview
Libo Pharma Corp.
Taiwan Province, China [Taiwan]libopharma.com ↗
- Ownership
- Public · 7888
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Libo Pharma Corp. is a clinical-stage biopharmaceutical company operating under a virtual/federated business model. It focuses on accelerating the development of novel therapeutics for unmet medical needs in oncology, hematology, immune disorders, and regenerative medicine. Its lead disclosed asset is a recombinant human interleukin‑12 targeting IL‑12R for cutaneous T-cell lymphoma at the preclinical stage. The company emphasizes stealth mode operations to protect early-stage assets and frequently partners with other pharmaceutical companies for co-development.[1][2][3][4][5]
- Therapeutic areas
- OncologyImmunologyNephrology
- Modalities
- Protein therapeutics (e.g., recombinant human interleukin)ImmunomodulatorsAntibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Engages in partnerships with pharmaceutical companies for co-development of assets ("Drug Discovery Alliance")[4]
Beyond the preview
Go deeper on Libo Pharma Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Libo Pharma Corp..